These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 20886718

  • 1. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM, Verzhbitskaia TIu, Tsaur GA, Shorikov EV, Savel'ev LI, Tsvirenko SV, Fechina LG.
    Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
    [Abstract] [Full Text] [Related]

  • 2. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M, Sun XF, Xu ZM, Zhang XY, Li FR, Wang XG, Chen XL, Lin HQ, Wen HG, Sun X, Song TW.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
    Lucio P, Gaipa G, van Lochem EG, van Wering ER, Porwit-MacDonald A, Faria T, Bjorklund E, Biondi A, van den Beemd MW, Baars E, Vidriales B, Parreira A, van Dongen JJ, San Miguel JF, Orfao A, BIOMED-I.
    Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early recovery of circulating immature B cells in B-lymphoblastic leukemia patients after CD19 targeted CAR T cell therapy: A pitfall for minimal residual disease detection.
    Xiao W, Salem D, McCoy CS, Lee D, Shah NN, Stetler-Stevenson M, Yuan CM.
    Cytometry B Clin Cytom; 2018 May; 94(3):434-443. PubMed ID: 28888074
    [Abstract] [Full Text] [Related]

  • 9. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
    Liu Y, Tang JY, Xu C, Gu LJ, Xue HL, Chen J, Pan C, Dong L, Zhou M.
    Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409
    [Abstract] [Full Text] [Related]

  • 10. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA, Spasova MI, Murdjeva MA, Stoyanova AA, Mumdziev IN, Kaleva VI, Belcheva MI, Bosheva MN.
    Folia Med (Plovdiv); 2016 Mar 01; 58(1):28-35. PubMed ID: 27383875
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J, Orfao A, Vidriales B, Macedo A, Martínez A, González M, López-Berges MC, Valverde B, San Miguel JF.
    Haematologica; 1998 Dec 01; 83(12):1069-75. PubMed ID: 9949623
    [Abstract] [Full Text] [Related]

  • 13. [Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis].
    Liu YR, Chen SS, Chang Y, Fu JY, Zhang LP, Wang H, Li LD, Zhu HH, Liu GL, Lu DP, Huang XJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct 01; 14(5):853-7. PubMed ID: 17096875
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The clinical significance of detecting minimal residual disease in acute childhood B-cell lymphoblastic leukemia with flow cytometry].
    Zhang LP, Cheng YF, Liu GL, Lu AD, Liu YR, Wang H.
    Zhonghua Er Ke Za Zhi; 2005 Jul 01; 43(7):481-5. PubMed ID: 16083543
    [Abstract] [Full Text] [Related]

  • 19. Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country.
    Patkar N, Alex AA, B B, Ahmed R, Abraham A, George B, Vishwabandya A, Srivastava A, Mathews V.
    Cytometry B Clin Cytom; 2012 Jul 01; 82(4):252-8. PubMed ID: 22467604
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
    Sidhom I, Shaaban K, Soliman S, Ezzat S, El-Anwar W, Hamdy N, Yassin D, Salem S, Hassanein H, Mansour MT.
    J Egypt Natl Canc Inst; 2008 Jun 01; 20(2):111-20. PubMed ID: 20029466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.